Profile data is unavailable for this security.
About the company
SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.
- Revenue in EUR (TTM)948.56m
- Net income in EUR150.41m
- Incorporated2022
- Employees4.65k
- LocationSCHOTT Pharma AG & Co KgaAHattenbergstrasse 10MAINZ 55122GermanyDEU
- Phone+49 6131660
- Fax+49 6 131662000
- Websitehttps://www.schott-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elekta AB (publ) | 1.61bn | 100.59m | 2.37bn | 4.57k | 24.44 | 2.58 | 11.56 | 1.47 | 2.96 | 2.96 | 47.38 | 28.01 | 0.5822 | 3.16 | 2.89 | 3,903,469.00 | 3.65 | 4.19 | 6.53 | 7.51 | 36.76 | 39.03 | 6.27 | 7.37 | 0.7425 | 3.91 | 0.4196 | 68.60 | 7.41 | 5.98 | 38.07 | 1.68 | 20.06 | 5.92 |
| Medacta Group SA | 546.05m | 56.39m | 2.67bn | 1.83k | 47.33 | 7.72 | 22.48 | 4.90 | 2.65 | 2.65 | 25.64 | 16.24 | 0.7908 | 0.85 | 5.62 | 296,173.20 | 8.17 | 7.89 | 10.36 | 10.57 | 67.93 | 70.43 | 10.33 | 10.09 | 0.845 | 11.02 | 0.4015 | 17.01 | 16.85 | 13.38 | 2.41 | 0.6937 | 8.32 | -- |
| Gerresheimer AG | 2.00bn | 115.11m | 2.76bn | 11.91k | 24.00 | 1.87 | 9.01 | 1.38 | 3.33 | 3.33 | 57.96 | 42.82 | 0.5838 | 4.00 | 6.68 | 171,666.00 | 3.42 | 3.31 | 4.63 | 4.75 | 29.35 | 29.72 | 5.86 | 5.94 | 0.5053 | 4.59 | 0.4425 | 42.68 | 9.54 | 7.79 | 20.81 | 9.00 | 23.42 | 1.68 |
| Vitrolife AB | 313.84m | -337.28m | 3.07bn | 1.12k | -- | 2.64 | -- | 9.79 | -28.06 | -28.06 | 26.11 | 96.72 | 0.1836 | 3.65 | 6.16 | 3,276,182.00 | -19.72 | -4.57 | -20.43 | -4.78 | 57.48 | 58.38 | -107.41 | -21.89 | 2.43 | 8.48 | 0.1379 | -- | 8.60 | 24.99 | -1,077.41 | -- | -7.95 | 3.30 |
| Ambu A/S | 705.86m | 60.35m | 4.13bn | 4.82k | 77.54 | 6.07 | 37.35 | 5.86 | 1.69 | 1.69 | 19.80 | 21.60 | 0.7459 | 2.18 | 7.17 | 1,140,165.00 | 6.38 | 3.81 | 7.37 | 4.62 | 58.88 | 59.37 | 8.55 | 5.43 | 1.51 | 74.38 | 0.0961 | 22.89 | 7.45 | 12.88 | 80.65 | -13.00 | 6.67 | -- |
| Sectra AB | 160.71m | 39.71m | 4.56bn | 1.22k | 122.26 | 33.05 | 93.93 | 28.38 | 2.32 | 2.32 | 9.40 | 8.59 | 0.6136 | -- | 3.63 | 1,503,436.00 | 15.16 | 15.75 | 28.08 | 29.52 | 47.01 | 64.95 | 24.71 | 19.59 | -- | -- | 0.027 | 0.00 | 26.84 | 4.06 | 14.25 | 16.58 | 48.37 | -- |
| SCHOTT Pharma AG & Co KgaA | 948.56m | 150.41m | 4.62bn | 4.65k | 30.62 | 6.02 | 21.81 | 4.87 | 1.00 | 1.00 | 6.31 | 5.10 | 0.7434 | 4.34 | 4.07 | 204,166.20 | 11.82 | -- | 16.42 | -- | 34.18 | -- | 15.90 | -- | 1.06 | -- | 0.1086 | -- | 9.43 | -- | 21.11 | -- | -- | -- |
| Getinge AB | 2.96bn | 229.32m | 4.94bn | 11.89k | 23.07 | 1.89 | 12.29 | 1.67 | 9.48 | 9.48 | 122.36 | 115.57 | 0.6168 | 2.48 | 7.04 | 2,839,084.00 | 4.81 | 5.31 | 6.35 | 6.98 | 46.27 | 47.83 | 7.79 | 8.69 | 0.6455 | 13.07 | 0.2136 | 37.87 | 12.49 | 5.66 | -3.17 | -- | -0.3944 | 34.49 |
| ConvaTec Group PLC | 1.97bn | 137.28m | 5.58bn | 10.13k | 40.73 | 3.76 | 16.75 | 2.83 | 0.0557 | 0.0557 | 0.8006 | 0.6039 | 0.5965 | 2.47 | 5.89 | 162,473.30 | 4.15 | 2.36 | 4.74 | 2.73 | 55.96 | 55.03 | 6.96 | 4.34 | 1.27 | 2.96 | 0.4604 | 127.29 | 3.37 | 3.18 | 107.15 | -6.93 | 12.37 | 31.41 |
| Amplifon SpA | 2.32bn | 161.58m | 5.84bn | 14.38k | 36.08 | 5.13 | 13.16 | 2.51 | 0.7153 | 0.7153 | 10.27 | 5.03 | 0.6229 | 21.46 | 10.96 | 161,594.30 | 4.33 | 4.31 | 6.53 | 5.81 | 24.56 | 59.01 | 6.95 | 7.28 | 0.3992 | 6.12 | 0.5921 | 34.26 | 6.65 | 10.66 | -12.21 | 9.08 | 12.68 | 15.68 |
| DiaSorin SpA | 1.16bn | 167.74m | 5.87bn | 3.19k | 34.82 | 3.46 | 19.33 | 5.05 | 3.01 | 3.01 | 21.78 | 30.31 | 0.3668 | 1.26 | 6.09 | 359,117.20 | 5.28 | 10.30 | 5.78 | 11.50 | 64.81 | 66.70 | 14.40 | 21.25 | 1.89 | 12.28 | 0.3892 | 24.71 | -15.64 | 11.40 | -33.65 | 0.2167 | 16.49 | -- |
| Ypsomed Holding AG | 584.49m | 83.52m | 5.99bn | 2.30k | 71.76 | 9.10 | 36.68 | 10.25 | 5.74 | 5.74 | 40.18 | 45.26 | 0.5587 | 5.40 | 4.96 | 238,875.00 | 7.98 | 4.41 | 12.40 | 6.81 | 34.47 | 27.26 | 14.29 | 7.38 | 0.5967 | 20.89 | 0.293 | 20.50 | 10.25 | 3.86 | 52.83 | 5.44 | 8.64 | 29.46 |
| Carl Zeiss Meditec AG | 2.07bn | 203.20m | 6.36bn | 4.95k | 31.23 | -- | -- | 3.08 | 2.28 | 2.28 | 23.14 | -- | -- | -- | -- | 428,397.90 | -- | 9.56 | -- | 11.72 | 55.12 | 57.84 | 9.84 | 13.15 | -- | -- | -- | 34.47 | 9.80 | 10.28 | -1.20 | 18.09 | 26.79 | 14.87 |
Data as of Sep 30 2024. Currency figures normalised to SCHOTT Pharma AG & Co KgaA's reporting currency: Euro EUR
10.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 20 Jun 2024 | 4.54m | 3.01% |
| T. Rowe Price International Ltd.as of 30 Jun 2024 | 2.87m | 1.90% |
| Union Investment Privatfonds GmbHas of 31 Mar 2024 | 1.79m | 1.19% |
| DWS Investment GmbHas of 28 Jun 2024 | 1.77m | 1.17% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 1.26m | 0.84% |
| Threadneedle Asset Management Ltd.as of 30 Jun 2024 | 1.26m | 0.84% |
| Lazard Asset Management Ltd.as of 31 May 2024 | 843.77k | 0.56% |
| Deka Investment GmbHas of 30 Jun 2024 | 689.05k | 0.46% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 350.36k | 0.23% |
| Schroder Investment Management Ltd.as of 30 Apr 2024 | 269.33k | 0.18% |
More ▼
Data from 31 Mar 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
